Halladay Benjamin
Insider CIK 1953943 · ESPR Chief Financial Officer · ACHV Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-10-05 | 2026-10-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-10-05 | 2026-10-06 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 200,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 213,000 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer deriv | 2026-07-13 | 2026-07-13 | 221,270 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | D To issuer | 2026-07-13 | 2026-07-13 | 705,410 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2026-06-17 | 2026-06-18 | 10,773 | $3.16 | $34.0K | 702,829 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2026-03-17 | 2026-03-18 | 6,424 | $2.71 | $17.4K | 713,602 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2026-03-13 | 2026-03-16 | 221,270 | — | $0 | 221,270 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2026-03-13 | 2026-03-16 | 247,430 | — | $0 | 720,026 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-12-17 | 2025-12-18 | 7,337 | $3.67 | $26.9K | 467,525 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-09-17 | 2025-09-18 | 7,046 | $2.81 | $19.8K | 474,862 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-07-17 | 2025-07-18 | 11 | $1.12 | $12 | 474,462 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-06-17 | 2025-06-18 | 7,229 | $1.15 | $8.3K | 474,473 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-04-17 | 2025-04-21 | 8 | $0.96 | $8 | 481,702 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-03-18 | 2025-03-19 | 3,535 | $1.48 | $5.2K | 481,710 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2025-03-14 | 2025-03-17 | 213,000 | — | $0 | 213,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2025-03-14 | 2025-03-17 | 238,000 | — | $0 | 485,245 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-02-19 | 2025-02-20 | 11 | $1.86 | $20 | 240,671 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2025-01-17 | 2025-01-21 | 9 | $2.27 | $20 | 240,682 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2024-12-17 | 2024-12-18 | 3,245 | $2.42 | $7.9K | 240,691 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2024-03-14 | 2024-03-15 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2024-03-14 | 2024-03-15 | 170,000 | — | $0 | 243,936 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2023-03-14 | 2023-03-15 | 39,000 | — | $0 | 39,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2023-03-14 | 2023-03-15 | 9,200 | — | $0 | 73,936 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2022-12-09 | 2022-12-12 | 66,000 | — | $0 | 66,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2022-12-09 | 2022-12-12 | 44,000 | — | $0 | 63,771 | SEC↗ |